<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03148236</url>
  </required_header>
  <id_info>
    <org_study_id>HM20006786</org_study_id>
    <nct_id>NCT03148236</nct_id>
  </id_info>
  <brief_title>Vitamin C in Atrial Fibrillation Ablation</brief_title>
  <acronym>VitC-AF</acronym>
  <official_title>Pilot Study of the Safety and Efficacy of Intravenous Vitamin C in Patients Undergoing Atrial Fibrillation Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-center, double-blinded, randomized, controlled safety and feasibility pilot study of
      high dose IV ascorbic acid (200mg/kg) over 24 hours, divided into four doses and administered
      every six hours with a 30 minute IV infusion time per dose, compared to matched placebo
      infusion
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 18, 2017</start_date>
  <completion_date type="Actual">March 13, 2018</completion_date>
  <primary_completion_date type="Actual">March 13, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Creatinine Levels</measure>
    <time_frame>Baseline to 24 hours</time_frame>
    <description>Change in Kidney Function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Plasma Levels of Ascorbic Acid</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Change in plasma levels of ascorbic acid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in hsCRP</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Biomarker of inflammation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Interleukin (IL-6)</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Biomarker of inflammation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Von Willebrand Factor (vWF)</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Biomarker of blood vessel damage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Creatinine Levels</measure>
    <time_frame>Baseline to 30 days</time_frame>
    <description>Change in kidney function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Plasma Ascorbic Acid Level</measure>
    <time_frame>Baseline to 30 days</time_frame>
    <description>Change in plasma ascorbic acid level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in hsCRP</measure>
    <time_frame>baseline to 30 days</time_frame>
    <description>Biomarker of inflammation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Interleukin (IL-6)</measure>
    <time_frame>baseline to 30 days</time_frame>
    <description>Biomarker of inflammation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Von Willebrand Factor (vWF)</measure>
    <time_frame>baseline to 30 days</time_frame>
    <description>Biomarker of blood vessel damage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post Procedural Pain</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Sum of pain scores every six hours for the 24 hour period following ablation measured on a visual analog scale scored on a level from zero (no pain) to 10 (maximum pain)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Atrial Fibrillation Ablation</condition>
  <arm_group>
    <arm_group_label>Vitamin C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin C</intervention_name>
    <description>200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
    <arm_group_label>Vitamin C</arm_group_label>
    <other_name>Ascorbic Acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>50mL infused over 30 minutes</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>D5W</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt;/= 21 years

          2. Diagnosis of atrial fibrillation with plans for a catheter-based ablation procedure

          3. Ability to provide informed consent and willingness to be included in the study

        Exclusion Criteria:

          1. Known allergy to Vitamin C

          2. Inability to obtain informed consent

          3. Diabetes mellitus either requiring the use of insulin therapy or not requiring the use
             of insulin therapy but which is uncontrolled, defined as a glycosylated hemoglobin of
             greater than or equal to 8%

          4. Prior catheter-based ablation for atrial fibrillation

          5. Pregnancy or breast feeding

          6. Active renal calculus

          7. Active acute or chronic infection (including HIV or hepatitis C)

          8. Active or recent (within 5 years) malignancy

          9. Autoimmune or autoinflammatory disease

         10. Recent or active use of immunosuppressive medications

         11. Non-English speaking

         12. Ward of the state (inmate, other)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jayanthe Koneru, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>May 1, 2017</study_first_submitted>
  <study_first_submitted_qc>May 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2017</study_first_posted>
  <results_first_submitted>February 22, 2019</results_first_submitted>
  <results_first_submitted_qc>March 28, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 16, 2019</results_first_posted>
  <last_update_submitted>March 28, 2019</last_update_submitted>
  <last_update_submitted_qc>March 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 23, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/36/NCT03148236/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Vitamin C</title>
          <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo: 50mL infused over 30 minutes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Vitamin C</title>
          <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo: 50mL infused over 30 minutes</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.5" lower_limit="56" upper_limit="69"/>
                    <measurement group_id="B2" value="65" lower_limit="54" upper_limit="70"/>
                    <measurement group_id="B3" value="63" lower_limit="56" upper_limit="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Creatinine Levels</title>
        <description>Change in Kidney Function</description>
        <time_frame>Baseline to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Creatinine Levels</title>
          <description>Change in Kidney Function</description>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" lower_limit="-0.2" upper_limit="-0.1"/>
                    <measurement group_id="O2" value="-0.1" lower_limit="-0.2" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Plasma Levels of Ascorbic Acid</title>
        <description>Change in plasma levels of ascorbic acid</description>
        <time_frame>baseline to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Plasma Levels of Ascorbic Acid</title>
          <description>Change in plasma levels of ascorbic acid</description>
          <units>micromolar</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="267" lower_limit="98" upper_limit="597"/>
                    <measurement group_id="O2" value="-4" lower_limit="-8" upper_limit="-1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in hsCRP</title>
        <description>Biomarker of inflammation</description>
        <time_frame>baseline to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in hsCRP</title>
          <description>Biomarker of inflammation</description>
          <units>mg/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.31" lower_limit="4.48" upper_limit="7.92"/>
                    <measurement group_id="O2" value="16.01" lower_limit="9.40" upper_limit="29.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Interleukin (IL-6)</title>
        <description>Biomarker of inflammation</description>
        <time_frame>baseline to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Interleukin (IL-6)</title>
          <description>Biomarker of inflammation</description>
          <units>pg/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.3" lower_limit="6.6" upper_limit="29.4"/>
                    <measurement group_id="O2" value="6.6" lower_limit="2.6" upper_limit="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Von Willebrand Factor (vWF)</title>
        <description>Biomarker of blood vessel damage</description>
        <time_frame>baseline to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Von Willebrand Factor (vWF)</title>
          <description>Biomarker of blood vessel damage</description>
          <units>micrograms/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" lower_limit="-1.3" upper_limit="4.8"/>
                    <measurement group_id="O2" value="0.4" lower_limit="-2.5" upper_limit="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Creatinine Levels</title>
        <description>Change in kidney function</description>
        <time_frame>Baseline to 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Creatinine Levels</title>
          <description>Change in kidney function</description>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-0.1" upper_limit="0"/>
                    <measurement group_id="O2" value="0.1" lower_limit="0" upper_limit="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Plasma Ascorbic Acid Level</title>
        <description>Change in plasma ascorbic acid level</description>
        <time_frame>Baseline to 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Plasma Ascorbic Acid Level</title>
          <description>Change in plasma ascorbic acid level</description>
          <units>micromolar</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="-10" upper_limit="21"/>
                    <measurement group_id="O2" value="-5" lower_limit="-12" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in hsCRP</title>
        <description>Biomarker of inflammation</description>
        <time_frame>baseline to 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in hsCRP</title>
          <description>Biomarker of inflammation</description>
          <units>mg/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.30" lower_limit="-1.16" upper_limit="0.32"/>
                    <measurement group_id="O2" value="-0.64" lower_limit="-2.70" upper_limit="-0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Interleukin (IL-6)</title>
        <description>Biomarker of inflammation</description>
        <time_frame>baseline to 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Interleukin (IL-6)</title>
          <description>Biomarker of inflammation</description>
          <units>pg/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-0.7" upper_limit="0.4"/>
                    <measurement group_id="O2" value="0.1" lower_limit="-0.6" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Von Willebrand Factor (vWF)</title>
        <description>Biomarker of blood vessel damage</description>
        <time_frame>baseline to 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Von Willebrand Factor (vWF)</title>
          <description>Biomarker of blood vessel damage</description>
          <units>micrograms/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3" lower_limit="-3.7" upper_limit="1.7"/>
                    <measurement group_id="O2" value="-3.8" lower_limit="-7.5" upper_limit="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post Procedural Pain</title>
        <description>Sum of pain scores every six hours for the 24 hour period following ablation measured on a visual analog scale scored on a level from zero (no pain) to 10 (maximum pain)</description>
        <time_frame>baseline to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin C</title>
            <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 50mL infused over 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Post Procedural Pain</title>
          <description>Sum of pain scores every six hours for the 24 hour period following ablation measured on a visual analog scale scored on a level from zero (no pain) to 10 (maximum pain)</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" lower_limit="1.3" upper_limit="9.8"/>
                    <measurement group_id="O2" value="0.3" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>90 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Vitamin C</title>
          <description>Vitamin C: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo: 50mL infused over 30 minutes</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Pericarditis</sub_title>
                <description>Pericarditis within 24 hours of the ablation.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Cory Trankle, MD</name_or_title>
      <organization>Virginia Commonwealth University</organization>
      <phone>804-213-2679</phone>
      <email>cory.trankle@vcuhealth.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

